Literature DB >> 26087970

Quality of life among testis cancer survivors.

Timothy Gilligan1.   

Abstract

BACKGROUND: As the most common cancer among males in late adolescence and early adulthood and as a disease with a 5-year relative survival rate of 96%, testis cancer has many survivors who live many years during which chronic toxicities may impair their quality of life.
METHODS: In this review, I aimed to summarize the most relevant literature on quality of life among testis cancer survivors identified via PubMed literature search between 1990 and 2015.
RESULTS: Survivors of testis cancer experience an overall quality of life (QOL) that is not measurably different from that of men of the same age in the general population. Nonetheless, testis cancer and its treatments can result in a variety of long-term conditions that affect QOL. These include peripheral neuropathy, hearing loss, tinnitus, fatigue, and Raynaud-like phenomenon. Exercise interventions have been shown to improve fatigue and overall QOL in cancer survivors, and there is evidence that psychosocial and mind-body interventions may also be beneficial. Pharmacological interventions have not been shown to be helpful for cancer-related fatigue, hearing loss, or neuropathy.
CONCLUSIONS: Testis cancer survivors should be asked about symptoms related to the conditions above and referred to specialists as indicated. Survivors complaining of fatigue should be encouraged to adopt a regular program of aerobic exercise.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fatigue; Germ cell tumors; Neuropathy; Quality of life; Survivors; Survivorship; Testis cancer

Mesh:

Year:  2015        PMID: 26087970     DOI: 10.1016/j.urolonc.2015.05.018

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  8 in total

1.  Performing Testicular Self-Examination, Driving Automobiles, and Anxiety: What Is the Logical Link?

Authors:  Michael J Rovito
Journal:  Am J Mens Health       Date:  2016-02-26

Review 2.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

Review 3.  From 'D' to 'I': A critique of the current United States preventive services task force recommendation for testicular cancer screening.

Authors:  Michael J Rovito; Janna Manjelievskaia; James E Leone; Michael J Lutz; Ajay Nangia
Journal:  Prev Med Rep       Date:  2016-04-21

4.  Malignant Transformation of Testicular Teratoma to PNET, Adenocarcinoma, and Osteosarcoma with Complete Remission after Surgery and Combination Chemotherapy in a Young Adult Male.

Authors:  Angela Shaw; Miriam Morrell; Annikka Weissferdt; Andrea Hayes-Jordan; Douglas Harrison
Journal:  Case Rep Oncol Med       Date:  2018-10-03

Review 5.  Psychosocial Issues in Long-Term Survivors of Testicular Cancer.

Authors:  Giuseppe Schepisi; Silvia De Padova; Delia De Lisi; Chiara Casadei; Elena Meggiolaro; Federica Ruffilli; Giovanni Rosti; Cristian Lolli; Giorgia Ravaglia; Vincenza Conteduca; Alberto Farolfi; Luigi Grassi; Ugo De Giorgi
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-25       Impact factor: 5.555

Review 6.  Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer.

Authors:  Xiaosong Meng; Murtaza Ahmed; Kevin D Courtney; Waddah Arafat; Ibrahim Ibrahim; Vitaly Margulis; Craig Nichols; Aditya Bagrodia
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

Review 7.  Late adverse effects and quality of life in survivors of testicular germ cell tumour.

Authors:  Michal Chovanec; Jakob Lauritsen; Mikkel Bandak; Christoph Oing; Gry Gundgaard Kier; Michael Kreiberg; Josephine Rosenvilde; Thomas Wagner; Carsten Bokemeyer; Gedske Daugaard
Journal:  Nat Rev Urol       Date:  2021-03-08       Impact factor: 14.432

8.  The Connection Between Testicular Cancer, Minority Males, and Planned Parenthood.

Authors:  Wesley B Adams; Michael J Rovito; Mike Craycraft
Journal:  Am J Mens Health       Date:  2018-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.